Ron Gilissen
- Pharmacology top 0.5%
- Molecular Biology
- Oncology top 10%
- Spectroscopy top 5%
- Infectious Diseases top 10%
- Co-authors
- Claire MackieVikash K. SinhaMarjoleen NijsenStefan S. De BuckLuca A. FenuMichael W.H. CoughtrieAndreas SmoldersJeroen Luyten
- Topics
- Pharmacogenetics and Drug Metabolism (11 papers)Drug Transport and Resistance Mechanisms (8 papers)Analytical Chemistry and Chromatography (5 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Ron Gilissen
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 566
- Molecular Biology 498
- Oncology 348
- Spectroscopy 153
- Infectious Diseases 126
Countries citing papers authored by Ron Gilissen
This map shows the geographic impact of Ron Gilissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Gilissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Gilissen more than expected).
Fields of papers citing papers by Ron Gilissen
This network shows the impact of papers produced by Ron Gilissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Gilissen. The network helps show where Ron Gilissen may publish in the future.
Co-authorship network of co-authors of Ron Gilissen
This figure shows the co-authorship network connecting the top 25 collaborators of Ron Gilissen. A scholar is included among the top collaborators of Ron Gilissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Gilissen. Ron Gilissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 15 | |
| 3 | 23 | |
| 4 | 4 | |
| 5 | 22 | |
| 6 | 37 | |
| 7 | 14 | |
| 8 | 75 | |
| 9 | 192 | |
| 10 | 7 | |
| 11 | 38 | |
| 12 | 57 | |
| 13 | 197 | |
| 14 | 5 | |
| 15 | 3 | |
| 16 | 17 | |
| 17 | 16 | |
| 18 | 7 | |
| 19 | 13 | |
| 20 | 10 |
About Ron Gilissen
Ron Gilissen is a scholar working on Pharmacology, Cancer Research and Statistics and Probability, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Pharmacology (566 citations), Ceramics and Composites (112 citations) and Oncology (348 citations). Ron Gilissen has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Claire Mackie, Vikash K. Sinha, Marjoleen Nijsen, Stefan S. De Buck, Luca A. Fenu, Michael W.H. Coughtrie, Andreas Smolders, Jeroen Luyten, Jean‐Pierre Erauw and Anthony A. Fryer. Their work appears in journals such as Cancer Research, Biochemical Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.